Medicago Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medicago Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12399
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline products includes pandemic flu vaccine and seasonal flu vaccines. Medicago’s seasonal flu vaccine is used for contagious respiratory illness. The company also develops H1N1 pandemic candidate vaccines; and rabies, rotavirus and biosimilar vaccination. It uses its technologies including plant-based proficia technology, virus-like particles and the VLPExpress platform for the development of vaccines. The company conducts research activities in the areas of biodefence and biosimilar therapies. It operates in North Carolina, and production facility in Canada. Medicago is headquartered in Quebec, Canada.

Medicago Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Medicago Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Medicago Enters into Contract with Public Health Agency of Canada 10
Medicago Enters into Agreement with University of Cape Town 11
Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12
Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13
Medicago Enters Into Co-Development Agreement With Cellectis 14
Licensing Agreements 15
Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 15
Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 16
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 17
Equity Offering 18
Medicago Announces Private Placement Of Common Stock For US$3.4 Million 18
Acquisition 19
Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For US$ 172 Million In Going Private Transaction 19
Medicago Inc – Key Competitors 21
Medicago Inc – Key Employees 22
Medicago Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Clinical Trials 24
Sep 27, 2017: Mitsubishi Tanabe Pharma: Notice of the Start of Phase 3 Clinical Study of VLP Seasonal Influenza Vaccine 24
Sep 26, 2017: Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine 25
Other Significant Developments 26
Sep 18, 2018: Medicago officially starts the construction of its site in Estimauville’s Innovation Area 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Medicago Inc, Pharmaceuticals & Healthcare, Key Facts 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medicago Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Medicago Enters into Contract with Public Health Agency of Canada 10
Medicago Enters into Agreement with University of Cape Town 11
Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12
Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13
Medicago Enters Into Co-Development Agreement With Cellectis 14
Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 15
Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 16
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 17
Medicago Announces Private Placement Of Common Stock For US$3.4 Million 18
Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For US$ 172 Million In Going Private Transaction 19
Medicago Inc, Key Competitors 21
Medicago Inc, Key Employees 22
Medicago Inc, Other Locations 23
Medicago Inc, Subsidiaries 23

List of Figures
Medicago Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medicago Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Medicago Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BBA Aviation plc (BBA):企業の財務・戦略的SWOT分析
    BBA Aviation plc (BBA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cascade Metrix LLC:製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that commercializes an automated POC blood analyzer for critical care. The company provides product portfolio such as novel micro-volume IV extension kits; and automated glucose monitoring systems, among others. It also provides a revo …
  • Panoro Energy ASA (PEN):企業の財務・戦略的SWOT分析
    Summary Panoro Energy ASA (Panoro) is an independent oil and gas exploration and development company that explores, develops and produces oil and gas properties in Brazil and West Africa. The company holds interests in production and exploration assets in Santos and Camamu Almada basins in Brazil. I …
  • Sims Metal Management Ltd:企業の戦略・SWOT・財務情報
    Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nuformix Plc (NFX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuformix Plc (Nuformix), formerly Levrett plc, is a pharmaceutical company which develops cocrystal forms of approved small molecules. Its product candidates which are in clinical and pre-clinical development include NXP001, NXP002, and NXP003 for the treatment of oncology supportive care an …
  • Naturgy Energy Group SA:企業の戦略・SWOT・財務分析
    Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report Summary Naturgy Energy Group SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sheridan Healthcare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sheridan Healthcare Inc (Sheridan Healthcare), a subsidiary of AmSurg Corp, is a healthcare service provider that offers physician services. The center offers office-based services in the areas of OBGYN, gynecology, gynecologic oncology, perinatology and pain management. It provides support, …
  • Torraspapel, S.A.:企業の戦略的SWOT分析
    Torraspapel, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Toyo Tanso Co Ltd (5310):企業の財務・戦略的SWOT分析
    Toyo Tanso Co Ltd (5310) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Viking Line ABP:企業の戦略・SWOT・財務情報
    Viking Line ABP - Strategy, SWOT and Corporate Finance Report Summary Viking Line ABP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Karyopharm Therapeutics Inc (KPTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Karyopharm Therapeutics Inc (Karyopharm Therapeutics) is a clinical-stage pharmaceutical company that discovers and develops novel drugs for the treatment of cancer and other diseases. The company develops small molecule selective inhibitor of nuclear export compounds that inhibit the nuclea …
  • NeuStar, Inc.:企業の戦略的SWOT分析
    NeuStar, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • New Age Metals Inc:企業の戦略・SWOT・財務分析
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Humana Inc (HUM)-医療機器分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Cembra Money Bank AG:企業の戦略・SWOT・財務情報
    Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report Summary Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alios BioPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alios BioPharma Inc (Alios BioPharma), a subsidiary of Janssen Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops novel therapies for treatment of viral diseases. The company offers drugs for the treatment of viral infections such as respiratory syncytial virus, i …
  • Singulus Technologies AG (SNG):電力:M&Aディール及び事業提携情報
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • Yue Yuen Industrial (Holdings) Limited:企業の戦略・SWOT・財務情報
    Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Passenger Rail Agency of South Africa:企業の戦略的SWOT分析
    Passenger Rail Agency of South Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Cosmos Insurance Public Company Ltd
    Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆